# Meg Jardine

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/meg-jardine/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,482 |
| Field | Diabetes Treatment and Management |
| h-index | 72 |
| i10-index | 189 |
| Last Known Institution | The University of Sydney |
| OpenAlex ID | https://openalex.org/A5107481474 |
| ORCID iD | https://orcid.org/0000-0002-0160-2375 |
| Works | 406 |

## Researcher papers

Showing 12 of 24.

- [Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/canagliflozin-and-renal-outcomes-in-type-2-diabetes-and-nephropathy/)
- [Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials](https://scholariq.org/papers/impact-of-diabetes-on-the-effects-of-sodium-glucose-co-transporter-2-inhibitors/)
- [Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes](https://scholariq.org/papers/albuminuria-and-kidney-function-independently-predict-cardiovascular-and-renal/)
- [Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy](https://scholariq.org/papers/global-kidney-health-2017-and-beyond-a-roadmap-for-closing-gaps-in-care-research/)
- [SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis](https://scholariq.org/papers/sglt2-inhibitors-for-the-prevention-of-kidney-failure-in-patients-with-type-2/)
- [Chronic Kidney Disease and Coronary Artery Disease](https://scholariq.org/papers/chronic-kidney-disease-and-coronary-artery-disease/)
- [Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-clinical-outcomes-in-patients-with-iga/)
- [Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/potassium-homeostasis-and-management-of-dyskalemia-in-kidney-diseases/)
- [Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials](https://scholariq.org/papers/effect-of-lowering-blood-pressure-on-cardiovascular-events-and-mortality-in/)
- [Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-decline-in-kidney-function-or-kidney/)
- [Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta‐analysis](https://scholariq.org/papers/effect-of-sglt2-inhibitors-on-cardiovascular-renal-and-safety-outcomes-in/)
- [Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups](https://scholariq.org/papers/canagliflozin-and-cardiovascular-and-renal-outcomes-in-type-2-diabetes-mellitus/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

## Researcher university

- [The University of Sydney](https://scholariq.org/institutions/the-university-of-sydney/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
